Cite
Ligand design for human acetylcholinesterase and nicotinic acetylcholine receptors, extending beyond the conventional and canonical
MLA
K. Barry Sharpless, et al. Ligand Design for Human Acetylcholinesterase and Nicotinic Acetylcholine Receptors, Extending beyond the Conventional and Canonical. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....09ef383abc5abeea87394290920645f8&authtype=sso&custid=ns315887.
APA
K. Barry Sharpless, Zoran Radić, William Fenical, Gisela Andrea Camacho-Hernandez, Yan Jye Shyong, Palmer Taylor, Zrinka Kovarik, Nathan M. Samskey, & Kwok Yiu Ho. (2021). Ligand design for human acetylcholinesterase and nicotinic acetylcholine receptors, extending beyond the conventional and canonical.
Chicago
K. Barry Sharpless, Zoran Radić, William Fenical, Gisela Andrea Camacho-Hernandez, Yan Jye Shyong, Palmer Taylor, Zrinka Kovarik, Nathan M. Samskey, and Kwok Yiu Ho. 2021. “Ligand Design for Human Acetylcholinesterase and Nicotinic Acetylcholine Receptors, Extending beyond the Conventional and Canonical,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....09ef383abc5abeea87394290920645f8&authtype=sso&custid=ns315887.